Johns Hopkins Medicine gets $17M, establishes psychedelic drug research center

Baltimore-based Johns Hopkins Medicine has established a Center for Psychedelic and Consciousness Research.

The teaching hospital and biomedical research facility received $17 million from private donors to launch the center. The center will focus on how psychedelic drugs affect behavior, brain function, learning and memory, the brain's biology and mood. Researchers hope the drugs can be used to treat such conditions as opioid addiction and Alzheimer's disease and create precision medicine treatments.

The center will provide training to graduate and medical students who want to pursue careers in psychedelic science.

The center's staff includes six faculty neuroscientists, experimental psychologists and clinicians with expertise in psychedelic science and five postdoctoral scientists.

"The center's establishment reflects a new era of research in therapeutics and the mind through studying this unique and remarkable class of pharmacological compounds," said Roland Griffiths, PhD, the center's director and professor of behavioral biology at the Johns Hopkins University School of Medicine.

More articles on healthcare quality:
Eleanor Health opens 1st outpatient addiction clinic in North Carolina
How Cincinnati Children's cut hospitalization rates 20% among high-risk youth
5 hospitals seeking CMOs




© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


IC Database-3

Top 40 Articles from the Past 6 Months